So how did the Cyprus-style bail-in come to America? Here’s how it works… The FSB (Financial Stability Board) writes a white paper and takes it across the hall to the BIS (Bank for International Settlements) both located in the same building shaped like a boot in Basel, Switzerland. The BIS and the G20 then rubber stamp this recommendation and the vassal countries like the USA then pass it into law without consultation with you, the sovereign citizen. So if you want to know who’s boss, it ain’t you pally.
“If you want a vision of the future, imagine a boot stamping on a human face – forever.”
–George Orwell
Carroll Quigley in “Tragedy and Hope”…
“The Power of financial capitalism had a far reaching plan, nothing less than to create a world system of financial control in private hands able to dominate the political system of each country and the economy of the world as a whole. This system was to be controlled in a feudalistic fashion by the central banks of the world acting in concert, by secret agreements arrived at in frequent meetings and conferences. The apex of the system was to be the Bank for International Settlements in Basel, Switzerland, a private bank owned and controlled by the world’s central banks, which were themselves private corporations.”
Letter to Col. Edward Mandell House (21 November 1933); as quoted in F.D.R.: His Personal Letters, 1928-1945, edited by Elliott Roosevelt (New York: Duell, Sloan and Pearce, 1950), pg. 373:
“The real truth of the matter is, as you and I know, that a financial element in the larger centers has owned the Government ever since the days of Andrew Jackson — and I am not wholly excepting the Administration of W. W. The country is going through a repetition of Jackson’s fight with the Bank of the United States — only on a far bigger and broader basis.”
Additional Reading:
Interesting to note that Basel, Switzerland is also the home of Novartis AG, a Pharmaceutical company, but not just any pharmaceutical company: Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland, ranking number one in sales among the world-wide industry in 2013. According to Bloomberg, in 2009 “the CDC agreed to pay London-based Glaxo and Novartis, based in Basel, Switzerland, more than $415 million for adjuvants that could be added to the swine flu vaccines, according to a July 13 statement”.